In reply to letter to editor regarding ``a multicenter, randomised, double-blind, imipenem/cilastatin-controlled clinical study of cefiderocol for the treatment of complicated urinary tract infections caused by Gram-negative pathogens in Chinese adults''

International Journal of Antimicrobial Agents · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles